Latest filing published 01 Sept 2026 for Crinetics Pharmaceuticals, Inc., €468k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Stephanie Okey span 3 companies, the busiest being PTC Therapeutics, Inc., Crinetics Pharmaceuticals, Inc. and Catalent, Inc. The record holds 25 filings, for trades running from 13 August 2021 to 1 September 2026.
Every open-market trade on record is a sale: 7 sales worth €867k. The totals do not cover 2 filings with an undisclosed amount. Outside the open market, there are 12 share grants and 2 option exercises. Since January 2026: no purchases and 4 sales on the market.
On 1 September 2026 came the latest disclosure, a transaction for €468k in Crinetics Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations